Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular Events

被引：0
|
作者：
Sara Lee
Christopher P. Cannon
机构：
[1] Temple University School of Pharmacy,Cardiovascular Division, Harvard Medical School
[2] Brigham and Women’s Hospital,undefined
来源：
Current Cardiology Reports | 2018年 / 20卷
关键词：
Statin therapy; PCSK9 inhibitors; Cholesterol; Cardiovascular risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Lipid-lowering Therapies in Myositis
    Mizus, Marisa C.
    Tiniakou, Eleni
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (10)
  • [22] UNMET NEEDS FOR LIPID-LOWERING THERAPY IN CARDIOVASCULAR EVENTS REDUCTION
    Zhou, Z.
    McCombs, J. S.
    VALUE IN HEALTH, 2019, 22 : S118 - S118
  • [23] Landmark Lipid-Lowering Trials in the Primary Prevention of Cardiovascular Disease
    Chrispin, Jonathan
    Martin, Seth S.
    Hasan, Rani K.
    Joshi, Parag H.
    Minder, C. Michael
    McEvoy, John W.
    Kohli, Payal
    Johnson, Amber E.
    Wang, Libin
    Blaha, Michael J.
    Blumenthal, Roger S.
    CLINICAL CARDIOLOGY, 2013, 36 (09) : 516 - 523
  • [24] Primary prevention of cardiovascular disease: Implications of lipid-lowering trials
    Pedersen, TR
    JOURNAL OF HYPERTENSION, 1996, 14 : S195 - S200
  • [25] New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk
    Graham, Ian
    Shear, Chuck
    De Graeff, Pieter
    Boulton, Caroline
    Catapano, Alberico L.
    Stough, Wendy Gattis
    Carlsson, Stefan C.
    De Backer, Guy
    Emmerich, Joseph
    Greenfeder, Scott
    Kim, Albert M.
    Lautsch, Dominik
    Nguyen, Tu
    Nissen, Steven E.
    Prasad, Krishna
    Ray, Kausik K.
    Robinson, Jennifer G.
    Sasiela, William J.
    Slot, Karsten Bruins
    Stroes, Erik
    Thuren, Tom
    Van der Schueren, Bart
    Velkovski-Rouyer, Maja
    Wasserman, Scott M.
    Wiklund, Olov
    Zouridakis, Emmanouil
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (02) : 119 - 127
  • [26] Clinical Update on Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
    Ray, Kausik K.
    Wright, R. Scott
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (21): : 2205 - 2205
  • [27] Comparative effects of lipid-lowering therapies
    Davidson, MH
    Toth, PP
    PROGRESS IN CARDIOVASCULAR DISEASES, 2004, 47 (02) : 73 - 104
  • [28] Personalize and Optimize Lipid-Lowering Therapies
    Weingaertner, Oliver
    Luetjohann, Dieter
    Elsaesser, Albrecht
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (03) : 325 - 326
  • [29] Lipid-lowering drug therapies: the evidence
    Packard, C
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2000, 59 (03) : 423 - 424
  • [30] Pharmacogenetics of Lipid-lowering Therapies.
    Ordovas J.M.
    Shen H.
    Current Atherosclerosis Reports, 2002, 4 (3) : 183 - 192
12345